These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 24260892)
1. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance]. Rybalkina EIu; Stromskaia TP; Ovchinnikov LP; Stavrovskaia AA Vopr Onkol; 2013; 59(5):623-8. PubMed ID: 24260892 [TBL] [Abstract][Full Text] [Related]
2. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR. Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity. Saupe M; Rauschenberger L; Preuß M; Oswald S; Fussek S; Zimmermann U; Walther R; Knabbe C; Burchardt M; Stope MB World J Urol; 2015 Oct; 33(10):1481-6. PubMed ID: 25544376 [TBL] [Abstract][Full Text] [Related]
4. [Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol]. Shi XY; Cai XJ; Lei JX; Cao FJ; Pan DF; Chen P Ai Zheng; 2008 Apr; 27(4):343-7. PubMed ID: 18423117 [TBL] [Abstract][Full Text] [Related]
5. The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma. Wang L; Lin N; Li Y Oncol Rep; 2019 Mar; 41(3):1678-1690. PubMed ID: 30664164 [TBL] [Abstract][Full Text] [Related]
6. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel. Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573 [TBL] [Abstract][Full Text] [Related]
7. [Effects of changwelqing on nuclear translocation of Y-box binding protein-1 and expression of P-glycoprotein in human colon cancer cell line with drug-resistance induced by vincristine]. Xu JH; Deng WL; Fan ZZ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):743-7. PubMed ID: 20929136 [TBL] [Abstract][Full Text] [Related]
8. Intracellular localization and content of YB-1 protein in multidrug resistant tumor cells. Vaiman AV; Stromskaya TP; Rybalkina EY; Sorokin AV; Guryanov SG; Zabotina TN; Mechetner EB; Ovchinnikov LP; Stavrovskaya AA Biochemistry (Mosc); 2006 Feb; 71(2):146-54. PubMed ID: 16489918 [TBL] [Abstract][Full Text] [Related]
9. The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer. Liu Z; Zhu G; Getzenberg RH; Veltri RW J Cell Biochem; 2015 Jul; 116(7):1341-9. PubMed ID: 25640606 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine. Xie X; Tang B; Zhou J; Gao Q; Zhang P Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression. McDonald GT; Sullivan R; Paré GC; Graham CH Exp Cell Res; 2010 Nov; 316(19):3197-206. PubMed ID: 20736003 [TBL] [Abstract][Full Text] [Related]
12. Influence of proteasome inhibitor bortezomib on the expression of multidrug resistance genes and Akt kinase activity. Panischeva LA; Kakpakova ES; Rybalkina EY; Stavrovskaya AA Biochemistry (Mosc); 2011 Sep; 76(9):1009-16. PubMed ID: 22082269 [TBL] [Abstract][Full Text] [Related]
13. Connection between Proliferation Rate and Temozolomide Sensitivity of Primary Glioblastoma Cell Culture and Expression of YB-1 and LRP/MVP. Moiseeva NI; Susova OY; Mitrofanov AA; Panteleev DY; Pavlova GV; Pustogarov NA; Stavrovskaya AA; Rybalkina EY Biochemistry (Mosc); 2016 Jun; 81(6):628-35. PubMed ID: 27301292 [TBL] [Abstract][Full Text] [Related]
14. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343 [TBL] [Abstract][Full Text] [Related]
15. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Barancík M; Bohácová V; Sedlák J; Sulová Z; Breier A Eur J Pharm Sci; 2006 Dec; 29(5):426-34. PubMed ID: 17010577 [TBL] [Abstract][Full Text] [Related]
16. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells]. Liu Y; Chen X; Luo Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280 [TBL] [Abstract][Full Text] [Related]
17. MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop. Sinnberg T; Sauer B; Holm P; Spangler B; Kuphal S; Bosserhoff A; Schittek B Exp Dermatol; 2012 Apr; 21(4):265-70. PubMed ID: 22417301 [TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines. Badinloo M; Esmaeili-Mahani S Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575 [TBL] [Abstract][Full Text] [Related]
19. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor. Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496 [TBL] [Abstract][Full Text] [Related]
20. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]